In Veritas Medical Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: December 1, 2016
Pages: 50
Price:
US$ 499.00
In Veritas Medical Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: I7118310084BEN
Leaflet:

Download PDF Leaflet

In Veritas Medical Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
In Veritas Medical Diagnostics Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between In Veritas Medical Diagnostics Inc. and its competitors. This provides our Clients with a clear understanding of In Veritas Medical Diagnostics Inc. position in the Healthcare Equipment/Supplies Industry.

  • The report contains detailed information about In Veritas Medical Diagnostics Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for In Veritas Medical Diagnostics Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The In Veritas Medical Diagnostics Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes In Veritas Medical Diagnostics Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of In Veritas Medical Diagnostics Inc. business.

About In Veritas Medical Diagnostics Inc.

In Veritas Medical Diagnostics, Inc., a development stage company, engages in the development of medical diagnostic products for personal and professional use in the field of near patient medical diagnostics, also known as ‘point of care’. The company focuses on creating point of care devices or systems for the minimally-invasive monitoring of patients.

Subsidiaries

The company’s subsidiaries include IVMD (UK) Ltd. and Jopejo Ltd.

Products

The company’s products include prothrombin blood coagulation time measuring device and Labour Onset Device.

Prothrombin Blood Coagulation Time Measuring Device

The prothrombin time is a laboratory measure used to determine the functionality of the blood coagulation system. It is used in patient care to diagnose a condition of blood coagulation, assess the risk of bleeding in patients undergoing operative procedures, monitor patients being treated with oral anticoagulant therapy, and evaluate liver function. The PT is performed by measuring the clotting time of platelet-poor plasma after the addition of calcium and thromboplastin, a combination of tissue factor and phospholipid.

Labour Onset Device

The company developed the prediction of labor onset (POLO) product. It has two phases of clinical trials conducted in Leeds, England.

Minimally invasive Biomarker Analysis products – Immunoassay

Immunoassay is a laboratory technique in the clinical chemistry laboratory being used to give qualitative and / or quantitative results for various species of analytes. The company has completed a demonstration version of its magnetic detection technology for a strip-based and hand-held quantitative immunoassay device.

Non-Invasive Blood Analyte Measurement Products

The company engages in the research and development of a non-Invasive Glucose (and other) concentration continuous bulk measuring device.

Medical Imaging

The company engages in the research and development of digital scanning machine, a noninvasive alternative to 2D X-ray scanning.

Bone Mineral Densitometry

The company engages in the research and development of an instant display of bonemineral density for osteoporosis patients.

Markets

The company markets its products in the United Kingdom, the United States of America, western Europe, India, and China.

Suppliers

The company’s supplier includes Scandinavian Micro Biodevices.

Competition

The company’s competitors include Johnson and Johnson, Roche Diagnostics, Abbott Medicines, and Bayer Diagnostics. It also competes with Beckman Coulter, Abbott Labs, Becton Dickinson, and Dade Behring.


The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

RESEARCH METHODOLOGY

DISCLAIMER

1. IN VERITAS MEDICAL DIAGNOSTICS INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. IN VERITAS MEDICAL DIAGNOSTICS INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. IN VERITAS MEDICAL DIAGNOSTICS INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. IN VERITAS MEDICAL DIAGNOSTICS INC. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. IN VERITAS MEDICAL DIAGNOSTICS INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. In Veritas Medical Diagnostics Inc. Direct Competitors
5.2. Comparison of In Veritas Medical Diagnostics Inc. and Direct Competitors Financial Ratios
5.3. Comparison of In Veritas Medical Diagnostics Inc. and Direct Competitors Stock Charts
5.4. In Veritas Medical Diagnostics Inc. Industry Analysis
  5.4.1. Healthcare Equipment/Supplies Industry Snapshot
  5.4.2. In Veritas Medical Diagnostics Inc. Industry Position Analysis

6. IN VERITAS MEDICAL DIAGNOSTICS INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. IN VERITAS MEDICAL DIAGNOSTICS INC. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. IN VERITAS MEDICAL DIAGNOSTICS INC. ENHANCED SWOT ANALYSIS2

9. UK PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. IN VERITAS MEDICAL DIAGNOSTICS INC. IFE, EFE, IE MATRICES2

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. IN VERITAS MEDICAL DIAGNOSTICS INC. PORTER FIVE FORCES ANALYSIS2

12. IN VERITAS MEDICAL DIAGNOSTICS INC. VRIO ANALYSIS2


APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

In Veritas Medical Diagnostics Inc. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
In Veritas Medical Diagnostics Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
In Veritas Medical Diagnostics Inc. Major Shareholders
In Veritas Medical Diagnostics Inc. History
In Veritas Medical Diagnostics Inc. Products
Revenues by Segment
Revenues by Region
In Veritas Medical Diagnostics Inc. Offices and Representations
In Veritas Medical Diagnostics Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
In Veritas Medical Diagnostics Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
In Veritas Medical Diagnostics Inc. Capital Market Snapshot
In Veritas Medical Diagnostics Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
In Veritas Medical Diagnostics Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
In Veritas Medical Diagnostics Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1

LIST OF FIGURES

In Veritas Medical Diagnostics Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
In Veritas Medical Diagnostics Inc. 1-year Stock Charts
In Veritas Medical Diagnostics Inc. 5-year Stock Charts
In Veritas Medical Diagnostics Inc. vs. Main Indexes 1-year Stock Chart
In Veritas Medical Diagnostics Inc. vs. Direct Competitors 1-year Stock Charts
In Veritas Medical Diagnostics Inc. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.


Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top


Ask Your Question

In Veritas Medical Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: